Analyst Ratings For Pacira BioSciences
Analyst Ratings For Pacira BioSciences
帕西拉生物科学的分析师评级
6 analysts have shared their evaluations of Pacira BioSciences (NASDAQ:PCRX) during the recent three months, expressing a mix of bullish and bearish perspectives.
最近三个月来，有6位分析师分享了他们对Pacira BioSciences（纳斯达克股票代码：PCRX）的评估，表达了看涨和看跌的观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表总结了他们最近的评估，说明了过去30天不断变化的情绪，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $46.67, a high estimate of $57.00, and a low estimate of $43.00. This current average has decreased by 4.76% from the previous average price target of $49.00.
分析师12个月目标股价的见解已经公布，平均目标股价为46.67美元，最高估计为57.00美元，低估值为43.00美元。目前的平均价格较之前的平均目标价49.00美元下降了4.76％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The perception of Pacira BioSciences by financial experts is analyzed through recent analyst actions...
通过分析师最近的行动，分析了...
登录免费看全文
登录/注册